Investor Ideas, Trading Ideas and Stocks to Watch : #AIEye #Podcast 584: #Stocks discussed: (NasdaqGS: $TWST) (NYSE: $MDLA) #artificialintelligence

Monday, July 26, 2021

#AIEye #Podcast 584: #Stocks discussed: (NasdaqGS: $TWST) (NYSE: $MDLA) #artificialintelligence

#AIEye #Podcast 584: #Stocks discussed: (NasdaqGS: $TWST) (NYSE: $MDLA) #artificialintelligence

Twist Bioscience Uses AI from MOLCURE for Antibody Discovery, and Medallia to be Acquired by Thoma Bravo

Global #AI in Diagnostics Market to Reach $5.37B by 2028

Point Roberts WA, Vancouver BC – July 26, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/072621-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/07261TWST-MDLA.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:TWST) (NYSE:MDLA)

Synthetic biology and genomics company Twist Bioscience Corporation (NasdaqGS:TWST) is incorporating AI technology from MOLCURE Inc. to augment therapeutic antibody discovery. Emily Leproust, CEO and co-founder of Twist Bioscience, commented:

"Twist Bioscience continues to innovate and incorporate the most advanced methods of antibody discovery and optimization into our processes. MOLCURE’s AI approach complements our proprietary antibody discovery and optimization efforts, leveraging technology to refine our internal antibody pipeline. Their platform enables us to find more leads derived from NGS sequencing from our library. We look forward to taking leads generated from this collaboration forward within our internal pipeline."

Medallia, Inc. (NYSE:MDLA) has entered into a definitive agreement to be acquired by software investment firm Thoma Bravo in an all-cash transaction valuing the former at $6.4 billion. According to the press release, this will see Medallia “become a private company with additional resources and greater flexibility to build on its innovation leadership and expand its customer impact.” Scott Crabill, a Managing Partner at Thoma Bravo, said:

"Medallia has positioned itself at the forefront of the experience management market with a best-in-class SaaS platform that leverages proprietary AI to help companies better understand their customers and employees and drive meaningful business growth at scale. Medallia’s ability to provide personalized and predictive insights across every channel and to companies of all sizes has become mission-critical in a rapidly expanding universe of structured and unstructured data, where more and more business is transacted digitally. We look forward to partnering with Leslie and the talented Medallia team and applying our operational and investment expertise in software to support the company in the next phase of its growth journey."

Global AI in Diagnostics Market to Reach $5.37B by 2028

A report published by Verified Market Research finds that the global AI in Diagnostics market will grow from $532.22 million in 2020 to $5.37 billion by 2028, registering a compound annual growth rate (CAGR) of 33.23 percent in the forecast period 2021-2028. An excerpt from the report’s description reads:

Key factors that are driving the market growth include the growing demand for reducing diagnostic cost, improving patient care, reducing machine downtime coupled with growing demand for low-cost diagnostic techniques, effective & efficient report analysis, and quick diagnostic data generation. Furthermore, advancements in AI and deep learning are expected to prove more efficient in identifying disease diagnoses over the next few years. Increasing adoption of AI-based diagnostics across the developed economies fosters market growth. For the past couple of decades, technological advancements in the healthcare sector are playing a vital role in strengthening the global healthcare infrastructure.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com